Racial and ethnic disparities post-hospitalization for COVID-19: barriers to access to care for survivors of COVID-19 acute respiratory distress syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 May 2024
Historique:
received: 20 12 2023
accepted: 30 04 2024
medline: 22 5 2024
pubmed: 22 5 2024
entrez: 21 5 2024
Statut: epublish

Résumé

Racial and ethnic health disparities in the incidence and severity of Coronavirus Disease 2019 (COVID-19) have been observed globally and in the United States. Research has focused on transmission, hospitalization, and mortality among racial and ethnic minorities, but Long COVID-19 health disparities research is limited. This study retrospectively evaluated 195 adults who survived COVID-19 associated acute respiratory distress syndrome (C-ARDS) in New York City from March-April 2020. Among survivors, 54% met the criteria for Long COVID syndrome. Hispanic/Latinx patients, were more likely to be uninsured (p = 0.027) and were less frequently discharged to rehabilitation facilities (p < 0.001). A cross-sectional telephone survey and interview were conducted with a subset of survivors (n = 69). Among these, 11% reported a lack of follow-up primary care post-discharge and 38% had subsequent emergency room visits. Notably, 38% reported poor treatment within the health care system, with 67% attributing this to racial or ethnic bias. Thematic analysis of interviews identified four perceived challenges: decline in functional status, discrimination during hospitalization, healthcare system inequities, and non-healthcare-related structural barriers. Sources of resilience included survivorship, faith, and family support. This study highlights structural and healthcare-related barriers rooted in perceived racism and poverty as factors impacting post-COVID-19 care.

Identifiants

pubmed: 38773184
doi: 10.1038/s41598-024-61097-0
pii: 10.1038/s41598-024-61097-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11556

Informations de copyright

© 2024. The Author(s).

Références

CDC. COVID data tracker. Centers for disease control and prevention. https://covid.cdc.gov/covid-data-tracker . (Accessed 20 September 2023) (2020).
CDC. Cases, data, and surveillance. Centers for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html (Accessed 10 May 2022) (2020).
CDC. Health equity. Centers for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.html (Accessed 10 May 2022) (2022).
Magesh, S. et al. Disparities in COVID-19 outcomes by race, ethnicity, and socioeconomic status: A systematic-review and meta-analysis. JAMA Netw. Open 4(11), e2134147. https://doi.org/10.1001/jamanetworkopen.2021.34147 (2021).
doi: 10.1001/jamanetworkopen.2021.34147 pubmed: 34762110 pmcid: 8586903
Ogedegbe, G. et al. Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in New York City. JAMA Netw. Open 3(12), e2026881. https://doi.org/10.1001/jamanetworkopen.2020.26881 (2020).
doi: 10.1001/jamanetworkopen.2020.26881 pubmed: 33275153 pmcid: 7718605
Mirajkar, A. et al. Racial disparities in patients hospitalized for COVID-19. J. Natl. Med. Assoc. 115(4), 436–440. https://doi.org/10.1016/j.jnma.2023.06.006 (2023).
doi: 10.1016/j.jnma.2023.06.006 pubmed: 37407381
Price-Haywood, E. G., Burton, J., Fort, D. & Seoane, L. Hospitalization and mortality among black patients and white patients with Covid-19. N. Engl. J. Med. 382(26), 2534–2543. https://doi.org/10.1056/NEJMsa2011686 (2020).
doi: 10.1056/NEJMsa2011686 pubmed: 32459916
Song, Z., Zhang, X., Patterson, L. J., Barnes, C. L. & Haas, D. A. Racial and ethnic disparities in hospitalization outcomes among medicare beneficiaries during the COVID-19 pandemic. JAMA Health Forum 2(12), e214223–e214223. https://doi.org/10.1001/jamahealthforum.2021.4223 (2021).
doi: 10.1001/jamahealthforum.2021.4223 pubmed: 35977303 pmcid: 8796953
Nakayama, L. F. et al. Post-discharge follow-up of patients with COVID-19: A Brazilian experience. SAGE Open Med. 10, 20503121221096600. https://doi.org/10.1177/20503121221096602 (2022).
doi: 10.1177/20503121221096602 pubmed: 35600705 pmcid: 9118893
Force, A. D. T. et al. Acute respiratory distress syndrome: The Berlin definition. JAMA 307(23), 2526–2533. https://doi.org/10.1001/jama.2012.5669 (2012).
doi: 10.1001/jama.2012.5669
Schenck, E. J. et al. Respiratory mechanics and gas exchange in COVID-19-associated respiratory failure. Ann. Am. Thorac. Soc. 17(9), 1158–1161. https://doi.org/10.1513/AnnalsATS.202005-427RL (2020).
doi: 10.1513/AnnalsATS.202005-427RL pubmed: 32432896 pmcid: 7462323
Ziehr, D. R. et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: A cohort study. Am. J. Respir. Crit. Care Med. 201(12), 1560–1564. https://doi.org/10.1164/rccm.202004-1163LE (2020).
doi: 10.1164/rccm.202004-1163LE pubmed: 32348678 pmcid: 7301734
Grasselli, G. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 323(16), 1574–1581. https://doi.org/10.1001/jama.2020.5394 (2020).
doi: 10.1001/jama.2020.5394 pubmed: 32250385 pmcid: 7136855
RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med 384(8), 693–704. https://doi.org/10.1056/NEJMoa2021436 (2020).
doi: 10.1056/NEJMoa2021436
Rosas, I. O. et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med. 384(16), 1503–1516. https://doi.org/10.1056/NEJMoa2028700 (2021).
doi: 10.1056/NEJMoa2028700 pubmed: 33631066
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: A prospective cohort study. Intensive Care Med. 47(1), 60–73. https://doi.org/10.1007/s00134-020-06294-x (2021).
doi: 10.1007/s00134-020-06294-x
Auld, S. C. et al. ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit. Care Med. 48(9), e799–e804. https://doi.org/10.1097/ccm.0000000000004457 (2020).
doi: 10.1097/ccm.0000000000004457 pubmed: 32452888
African C-CCOSI. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): A multicentre, prospective, observational cohort study. Lancet 397(10288), 1885–1894. https://doi.org/10.1016/S0140-6736(21)00441-4 (2021).
doi: 10.1016/S0140-6736(21)00441-4
Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet 395(10239), 1763–1770. https://doi.org/10.1016/S0140-6736(20)31189-2 (2020).
doi: 10.1016/S0140-6736(20)31189-2 pubmed: 32442528 pmcid: 7237188
Karagiannidis, C. et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: An observational study. Lancet Respir. Med. 8(9), 853–862. https://doi.org/10.1016/S2213-2600(20)30316-7 (2020).
doi: 10.1016/S2213-2600(20)30316-7 pubmed: 32735842 pmcid: 7386882
Aranda, J. et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J. Infect. 83(5), 581–588. https://doi.org/10.1016/j.jinf.2021.08.018 (2021).
doi: 10.1016/j.jinf.2021.08.018 pubmed: 34400219 pmcid: 8363182
Gamberini, L. et al. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up. Qual. Life Res. 30(10), 2805–2817. https://doi.org/10.1007/s11136-021-02865-7 (2021).
doi: 10.1007/s11136-021-02865-7 pubmed: 33977415 pmcid: 8113006
Flash Moses, J. E. et al. Disparities in post-intensive care syndrome during the COVID-19 pandemic: Challenges and solutions. Catal. Non-Issue Content https://doi.org/10.1056/CAT.20.0568 (2020).
doi: 10.1056/CAT.20.0568
Needham, D. M. et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit. Care Med. 40(2), 502–509. https://doi.org/10.1097/CCM.0b013e318232da75 (2012).
doi: 10.1097/CCM.0b013e318232da75 pubmed: 21946660
Kumar, G. et al. The association of lacking insurance with outcomes of severe sepsis: Retrospective analysis of an administrative database*. Crit. Care Med. 42(3), 583–591. https://doi.org/10.1097/01.ccm.0000435667.15070.9c (2014).
doi: 10.1097/01.ccm.0000435667.15070.9c pubmed: 24152590 pmcid: 4990450
Kahn, J. M., Benson, N. M., Appleby, D., Carson, S. S. & Iwashyna, T. J. Long-term acute care hospital utilization after critical illness. JAMA 303(22), 2253–2259. https://doi.org/10.1001/jama.2010.761 (2010).
doi: 10.1001/jama.2010.761 pubmed: 20530778 pmcid: 3094575
Lane-Fall, M. B., Iwashyna, T. J., Cooke, C. R., Benson, N. M. & Kahn, J. M. Insurance and racial differences in long-term acute care utilization after critical illness. Crit. Care Med. 40(4), 1143–1149. https://doi.org/10.1097/CCM.0b013e318237706b (2012).
doi: 10.1097/CCM.0b013e318237706b pubmed: 22020247
Richardson, S. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20), 2052–2059. https://doi.org/10.1001/jama.2020.6775 (2020).
doi: 10.1001/jama.2020.6775 pubmed: 32320003 pmcid: 7177629
Sinha, P. et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am. J. Respir. Crit. Care Med. 204(11), 1274–1285. https://doi.org/10.1164/rccm.202105-1302OC (2021).
doi: 10.1164/rccm.202105-1302OC pubmed: 34543591 pmcid: 8786071
Gorman, E. A., O’Kane, C. M. & McAuley, D. F. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management. Lancet 400(10358), 1157–1170. https://doi.org/10.1016/s0140-6736(22)01439-8 (2022).
doi: 10.1016/s0140-6736(22)01439-8 pubmed: 36070788
Krieger, N., Smith, K., Naishadham, D., Hartman, C. & Barbeau, E. M. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc. Sci. Med. 61(7), 1576–1596. https://doi.org/10.1016/j.socscimed.2005.03.006 (2005).
doi: 10.1016/j.socscimed.2005.03.006 pubmed: 16005789
Peek, M. E., Nunez-Smith, M., Drum, M. & Lewis, T. T. Adapting the everyday discrimination scale to medical settings: Reliability and validity testing in a sample of African American patients. Ethn. Dis. Autumn 21(4), 502–509 (2011).
Braun, V. & Clarke, V. Using thematic analysis in psychology. Qual. Res. Psychol. 3(2), 77–101 (2006).
doi: 10.1191/1478088706qp063oa
Krieger, N. Discrimination and health inequities. Int. J. Health Serv. 44(4), 643–710. https://doi.org/10.2190/HS.44.4.b (2014).
doi: 10.2190/HS.44.4.b pubmed: 25626224
Khullar, D. et al. Racial/Ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program. J. Gen. Intern. Med. 38(5), 1127–1136. https://doi.org/10.1007/s11606-022-07997-1 (2023).
doi: 10.1007/s11606-022-07997-1 pubmed: 36795327 pmcid: 9933823
Pfaff, E. R. et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med. 21, 58. https://doi.org/10.1186/s12916-023-02737-6 (2023).
doi: 10.1186/s12916-023-02737-6 pubmed: 36793086 pmcid: 9931566
Cullen, W., Gulati, G. & Kelly, B. D. Mental health in the COVID-19 pandemic. QJM 113(5), 311–312. https://doi.org/10.1093/qjmed/hcaa110 (2020).
doi: 10.1093/qjmed/hcaa110 pubmed: 32227218

Auteurs

Alicia Cañas (A)

Department of Medicine, Columbia University Medical Center, New York City, USA.

Allison Wolf (A)

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York City, USA.

En Chi Chen (EC)

School of Global Health, Dahdaleh Institute of Global Health Research, York University, Toronto, Canada.

Jacob Ruddy (J)

Department of Medicine, Columbia University Medical Center, New York City, USA.

Sal El-Sadek (S)

Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York City, USA.

Laura Gomez (L)

Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York City, USA.

David Furfaro (D)

Division of Pulmonary, Allergy, and Critical Care Medicine, Beth Israel Deaconess Medical Center, Brookline, MA, USA.

Robert Fullilove (R)

Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University Medical Center, New York City, USA.

Kristin M Burkart (KM)

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Center, New York City, USA.

Jennifer Zelnick (J)

Graduate School of Social Work, Touro University, New York City, USA.

Max R O'Donnell (MR)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Epidemiology, Columbia University Medical Center, Suite E101, 8th Floor, PH building, 622 W. 168th street, New York City, NY, 10032, USA. mo2130@columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH